Blend CJC-1295 no DAC + Ipamorelin

Name: Blend CJC-1295 no DAC + Ipamorelin
Brand: Live Fundamental
SKU: 431
Price: 63.99 USD
Availability: InStock

CJC-1295 (no DAC) + Ipamorelin is a two-component research blend combining a GHRH analog with a selective ghrelin-receptor agonist, studied in published literature for GH-axis receptor pharmacology. For laboratory research use only. Not for human consumption.

$63.99

Vial Content

Clear

Essential Specs

Class: Two-component GHRH analog / ghrelin-receptor agonist research blend | Source: Synthetic peptides | Format: Lyophilized powder, requires reconstitution for laboratory use

Storage & Handling

Storage: 2–8°C refrigerated, protect from light

Certificate of Analysis

Not yet available for this listing. Check verification status →

Research Summary

What Is CJC-1295 (no DAC) + Ipamorelin Blend? This is a two-component research blend combining CJC-1295 no DAC, a GHRH analog, with Ipamorelin, a selective ghrelin-receptor agonist. Each component is classified within the growth-hormone-axis peptide research family.

Molecular & Research Background Literature on GHRH analogs and selective ghrelin-receptor agonists describes complementary receptor pathways associated with pulsatile GH-axis signaling, examined in preclinical research combining these peptide classes.

Scientific References

Product-specific citation lists for this listing are being compiled and will be added as they become available. In the meantime, researchers can consult PubMed and other peer-reviewed literature databases for background on this compound class.

Shipping & FAQ

For shipping timelines, order tracking, and answers to common questions, visit our FAQ page or contact us directly.

Research Use Only

This product is offered strictly for laboratory and in-vitro research use. It is not a drug, dietary supplement, or consumer product, and it is not labeled, marketed, or intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease or condition. It has not been evaluated by the FDA. No claims are made regarding its safety or efficacy for any use outside a controlled research setting. Handling should be restricted to qualified researchers in appropriate laboratory environments. Not for human consumption.